Neuralynx

Neuralynx is a neurotechnology and medical-device company focused on electrophysiology data acquisition systems, software, and accessories for neuroscience research and human neurophysiology applications. The company’s products support neural signal recording, stimulation, experiment control, and data analysis in both preclinical laboratory and clinical settings. Its best-known offerings include the Digital Lynx family for multichannel neural recording and the ATLAS Neurophysiology System for human recording environments, including epilepsy-related applications. Founded by Casey Stengel, Neuralynx became part of FHC in 2021 and continues to operate as an active brand within FHC’s family of neuroscience products. The business is commercial-stage and generates revenue from hardware, software, support, maintenance, and related accessories rather than from a therapeutic drug pipeline.